PubRank

Tomoko Nukui

Author PubWeight™ 14.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov 2013 2.29
2 A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet 2011 1.68
3 Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst 2011 1.27
4 Pathologic and gene expression features of metastatic melanomas to the brain. Cancer 2013 1.01
5 The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study. Am J Med Genet B Neuropsychiatr Genet 2009 0.91
6 Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer. Mol Carcinog 2011 0.89
7 A sex-specific association between a 15q25 variant and upper aerodigestive tract cancers. Cancer Epidemiol Biomarkers Prev 2011 0.88
8 Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. Oncol Rep 2010 0.84
9 Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent. Cancer Epidemiol Biomarkers Prev 2011 0.81
10 Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer. Am J Respir Crit Care Med 2014 0.80
11 Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions. J Thorac Oncol 2015 0.78
12 CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer. Subst Use Misuse 2013 0.77
13 Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors. Cancer Epidemiol 2013 0.75
14 Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancer. J Thorac Oncol 2014 0.75